Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...

Competing interests: The author (s) declare that they have no competing interests. Cite this: Hydroxyurea And Sickle Cell Anemia: Effect On Quality Of Life - Medscape - Aug 31, 2006.

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

In just over a year since its launch, India’s National Sickle Cell Elimination Mission (NSCEM) is already demonstrating a ...

Cellarity has dosed the first subject in a Phase I study of oral medication, CLY-124, to treat sickle cell disease (SCD).

The intricate, hidden processes that sustain coral life are being revealed through a new microscope developed by scientists ...

The intricate, hidden processes that sustain coral life are being revealed through a new microscope developed by scientists ...

Corresponding author Akshay Sharma, MBBS, MSc, St. Jude Department of Bone Marrow Transplantation and Cellular Therapy talks ...

Engineered chip mimics bone marrow and immune system, offering a faster, tailored path for cancer immunotherapy.

A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...

Mar. 2, 2025 — Red blood cells carry oxygen from the lungs to every other organ, and blood-forming stem cells must make about 200 billion new red blood cells each day to keep the oxygen flowing ...